Premier Veterinary Group plc (formerly Ark Therapeutics Group plc) comprises of three groups of branches based in Bristol, on the North Kent coast and around the West Midlands, Shropshire and Gloucestershire. There are 15 practices in total and are known locally as Zetland and Thanet Veterinary Groups. Zetland Veterinary Group – is a cluster of practices based mainly in the central and north-west sector of Bristol. It comprises of a main hospital in Zetland Road and seven feeder branches, with 89 employees, including 20 vets. The group handles its own Out of Hours service with dedicated night nurses and the use of daytime vets. The group performs surgical procedures at six of the eight premises and has X-ray and ultrasound facilities at four of them. Complex surgical and diagnostic procedures are referred back to the hospital, which also has its own internal laboratory. Thanet Veterinary Group – is a group based on the North Kent coast, consisting of the main hospital in Margate and two feeder branches in Birchington and Westgate. The practice has 22 employees, including 4 vets. All surgery and diagnostic procedures are performed at the main hospital, which is equipped with X-ray, ultrasound and internal laboratory facilities. Bearwood Veterinary Group - consists of 2 clinics in the West Midlands. Bearwood, which is situated in Smethwick, near Birmingham City Centre, and the other in Maypole. The group has 15 employees, including 4 vets. The clinics have dedicated and friendly teams, committed to providing excellent professional care, with the latest veterinary clinical technology.

Major Agreement Signed in the US

RNS


RNS Number : 9654Z

Premier Veterinary Group PLC

02 June 2016


PREMIER VETERINARY GROUP PLC

("PVG" or "the Company")


MAJOR AGREEMENT SIGNED IN THE US FOR PREMIER PET CARE PLAN

London, UK, 2 June 2016 - Premier Veterinary Group plc (LSE: PVG) announces that its wholly-owned subsidiary, Premier Vet Alliance (US) Limited ("PVA"), has signed a major agreement with Veterinary Products, Inc. ("VPI"), a significant veterinary distributor co-op, headquartered in Atlanta, Georgia, US.

The contract is to supply the Company's preventative healthcare program for pets, branded in the US as "Premier Pet Care Plan" ("PPCP"), to VPI's member hospitals numbering over 600 across 15 States, located primarily in the South East of the US.

The initial 5-year agreement is to introduce PPCP to VPI's member hospitals and the target over the contract period is to reach at least 200,000 pets on plan. The first pets on plan are expected during the second half of the calendar year.



Bob MacDonald, President of VPI, commented:

"VPI has run wellness programs in the past, but PVA is the first to come to us with a model that delivers a product-led program with a comprehensive support package and delivering an end-to-end solution. We are a veterinarian and product driven distributor with very efficient delivery systems, and PVA meets our exacting requirements on customer service."

Dominic Tonner, Chief Executive Officer of PVG, added:

"We are delighted to have secured such a prestigious contract so soon after announcing our entry into the US market last month with our first 10 signed hospital contracts. VPI is an award winning business and a highly respected industry player. We look forward to a rapid and successful roll-out of our Premier Pet Care Plan across the VPI membership."

PREMIER PET CARE PLAN LAUNCHED IN FRANCE

RNS


RNS Number : 6753A

Premier Veterinary Group PLC

09 June 2016








PREMIER VETERINARY GROUP plc

("PVG" or "the Company")



PREMIER PET CARE PLAN LAUNCHED IN FRANCE AS PREMIER VETOPLAN



London, UK, 9 June 2016 - Premier Veterinary Group plc (LSE: PVG) announces that its preventative healthcare program for pets, branded "Premier Pet Care Plan" ("PPCP") in the UK, has been launched in France as Premier VetoPlan ("PVP") following the recent France Vet exhibition.



The first Business Development Manager and support training manager have been appointed and the initial primary focus will be on Paris and the Ile de France region that surrounds the capital. At the France Vet exhibition, the first contract for PVP was signed with a clinic in Toulouse in the south of the country.



The available market for preventative healthcare programs for pets across France is estimated at over 7 million dogs - similar to the UK - and over 11 million cats - more than 30% higher than the UK (Source: FACCO, France). There are approximately 6,000 veterinary practices in France.



Dominic Tonner, Chief Executive Officer of PVG, commented:



"Following our successful rollout of PPCP in the Netherlands, we have been reviewing the market opportunity in several other major European territories. We have now launched a bespoke preventative healthcare program for France where we see an exciting opportunity for rapid growth."

Further agreement signed in the US

Cooperation Agreement Signed With Zoetis

RNS


RNS Number : 8243F

Premier Veterinary Group PLC

01 August 2016








PREMIER VETERINARY GROUP plc

("PVG" or "the Company")



PREMIER PET CARE PLAN COOPERATION AGREEMENT SIGNED WITH ZOETIS (NETHERLANDS)



London, UK, 1 August 2016 - Premier Veterinary Group plc (LSE: PVG) announces that, through its wholly-owned subsidiary, Premier Vet Alliance Limited, it has signed a cooperation agreement for its preventative healthcare program for pets, Premier Pet Care Plan ("PPCP"), with Zoetis, one of the world's largest animal healthcare companies. PPCP is branded as "Huisdieren Zorg Plan" ("HZP") in the Netherlands.



Since the introduction of HZP to the Dutch companion animal market in March 2015, the business has entered into contracts with over 10% of the available clinic market. The cooperation agreement signed with Zoetis, an influential global manufacturer serving this market, will result in their representatives identifying and supporting practices which are interested in launching HZP in the Netherlands. Working in close collaboration with Zoetis is expected to generate an acceleration of the penetration of HZP into the wider Dutch market.



The available market for preventative healthcare programs for pets across the Netherlands is estimated at 1,100 veterinary practices, and an estimated 1.5 million dogs and 2.6 million cats (Source: FEDIAF - 2012).



Peter Mijten, Business Unit Director Companion Animal & Equine - Benelux, Zoetis, commented:



"Zoetis is always looking for partnerships that can deliver innovative services to the veterinary clinics. The collaboration with Premier Vet Alliance reflects the choice for a partner that shares the same values as Zoetis: innovation, quality and customer centricity."



Dominic Tonner, Chief Executive Officer of PVG, commented:



"Following the successful rollout of HZP in the Netherlands, this collaboration agreement comes as result of Zoetis recognising the benefits to themselves and their customers in running a preventative healthcare program. We would anticipate this relationship resulting in an increase in referrals to us of practices with an interest in launching our preventative healthcare programs."

US EXPANSION UPDATE AND ISSUE OF LOAN NOTES

RNS


RNS Number : 0090K

Premier Veterinary Group PLC

16 September 2016










PREMIER VETERINARY GROUP plc

("PVG" or "the Company")





US EXPANSION UPDATE AND ISSUE OF LOAN NOTES





London, UK, 16 September 2016 - Premier Veterinary Group plc (LSE: PVG) provides an update on its expansion into the US and announces the issue of Loan Notes to fund the acceleration of this strategy.



In May this year, the Company announced the commencement of its expansion into the US for its preventative healthcare program for pets branded Premier Pet Care Plan ("PPCP") with the appointment of two Regional Sales Directors, based out of Atlanta, Georgia and Charlotte, North Carolina, and the recruitment of two launching/training staff.

In early June, the Company announced that it had signed a major agreement with Veterinary Products, Inc. ("VPI"), a significant veterinary distributor co-op, headquartered in Atlanta, Georgia, US to promote and rollout the Company's PPCP to VPI's member hospitals numbering over 600 across 15 States, located primarily in the South East of the US.

At the end of June, the Company issued a further announcement confirming that it had signed another major agreement in the US for PPCP. That agreement was entered into with Merritt Veterinary Supplies Inc. ("MVS"), a leading veterinary supplies distributor founded in 1938, which has 9,000 member hospitals in the south east of the US. MVS is headquartered in Columbia, South Carolina. Recruitment of the product launch and training team was quickly commenced to service this substantial account, to be supported by MVS' internal 42-strong sales team.

As previously indicated, the Company had planned for a methodical build-up of its presence in the US with the appointment of additional sales and training personnel to support the product in due course. However, the rapid rate of expansion into the US has greatly surpassed the Company's expectations and, in order to capitalise on the high level of interest that has been shown to date in the take-up of PPCP, further trainers will need to be recruited in the US much sooner than had originally been predicted. The Company's US subsidiary, Premier Vet Alliance LLC, already employs eight staff in the US and it is envisaged that a further resource will need to be recruited to handle the higher than anticipated level of hospital launches.

As at 15 September 2016 agreements have been signed with 29 hospitals in the US, with 5 hospitals launched to date. The Company has also commenced the collection of recurring payments in relation to the first pets on plan. The available market for preventative healthcare programs for pets across the US is estimated at 70 million dogs and 74 million cats (U.S. Pet Ownership & Demographics Sourcebook 2012).

Over the past two years, the Company has invested heavily in the development of its bespoke software system to facilitate the worldwide operation of PPCP, and the Company is pleased to report that this software is now fully functioning and operating to specification in Europe and the United States.

The directors have looked at a number of strategies for financing the Company's continued expansion in the US while avoiding dilution for existing shareholders and have concluded that debt funding provides the most appropriate solution for the Company. On that basis, the Company has agreed terms for an aggregate issue of £1.25m of unsecured Loan Notes to existing and new investors in the Company split as follows:

External third parties: £600,000

Juliet Thompson, a Non-Executive Director and Chairman of the Company: £100,000

Timothy Thompson, Mrs Thompson's spouse: £200,000

Bybrook Finance Solutions Limited (of which Rajan Uppal,

an Executive Director of the Company, is sole director and shareholder): £350,000



The first tranche of Loan Notes totalling £900,000 will be issued immediately, with a further tranche from Bybrook Finance Solutions Limited with a value of £350,000 irrevocably committed for draw down by the end of the year. The Loan Notes mature after 18 months, and with a maximum total associated cost of £225,000 (equating to 12% interest). The Company has the right to repay the Loan Notes in full or in part before maturity. Early repayment would result in a minimum of nine months' interest being paid to the Loan Note holders, pro-rated in respect of investments made subsequent to the date of receipt of the first tranche. The Loan Notes are not capable of being converted into new ordinary shares in the Company.

In addition, the Company is in discussions with HSBC to put in place an overdraft facility to supplement further the working capital as the Company seeks to maximise the benefits of the US expansion opportunity.

Dominic Tonner, Chief Executive Officer of PVG, commented:



"Our detailed and lengthy research into the US market identified a clear and very significant opportunity for growth, starting in the south east of the country. Recently won contracts with industry majors in the veterinary distribution channels have accelerated our initial progress beyond our early expectations. We are now gearing up for more rapid rollout and expansion led by our very experienced local and central management teams."

Trading statement

Final Results
RNS
RNS Number : 3606Q
Premier Veterinary Group PLC
29 November 2016
 
PREMIER VETERINARY GROUP PLC
 
 
PRELIMINARY ANNOUNCEMENT - FINAL RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 AND NOTICE OF ANNUAL GENERAL MEETING
 
 
CONTINUING RAPID GROWTH IN CUSTOMER BASE FOR PREMIER PET CARE PLAN
 
 
 
 
London, UK, 29 November 2016 - Premier Veterinary Group plc (LSE: PVG) ("PVG" or the "Company") today announces its audited results for the year ended 30 September 2016.
 
Dominic Tonner, CEO of PVG commented:
 
"The significant progress made over the last 12 months in Europe and the US has helped develop a clear path for investing in sustainable aggressive growth over the next 5 years.  The Company's research across many countries indicates an opportunity to build a major global enterprise to deliver substantial returns to shareholders.
 
The Board remains confident in the Group's prospects and in its ability to deliver the expansion strategy."
 
HIGHLIGHTS
 
·           Disposal -of wholly-owned subsidiaries, Zetland Limited, Thanet One Limited and The Veterinary Clinic (Bearwood) Limited (the "Veterinary Business") for total consideration of £6.5m in December 2015.  £1m placed into escrow to cover potential liabilities under warranty and indemnity provisions in the sale and purchase agreement, expected to be released in December 2016.
·           22% increase in contracted clinics with 1,076 clinics in UK, US, Republic of Ireland, Denmark, the Netherlands, France and Germany at year end (30 September 2015: 880).
·           33% increase in total revenue from continuing operations (Premier Pet Care Plan and Premier Buying Group) to £2.99m for the year ended 30 September 2016 (30 September 2015: £2.25m).
·           75% increase in global revenues from Premier Pet Care Plan to £1.87m for the year ended 30 September 2016 (30 September 2015: £1.07m).
·           70% increase in pets on plan with 139,000 on plan at 30 September 2016 (30 September 2015: 82,000).
·           53% increase in pets on plan in the UK to 121,000 at 30 September 2016 (30 September 2015: 79,000).
·           77% increase in the number of global direct debits processed to 1,402,000 in year ended 30 September 2016 (30 September 2015: 794,000).
·           Revenue generation from Premier Buying Group steady at £1.1m for the year to 30 September 2016 (30 September 2015: £1.2m).
 
 
A full copy of the Company's Annual Report and Accounts for the year ended 30 September 2016 (incorporating the Notice of Annual General Meeting) ("Annual Report") will be available shortly on its website at www.premiervetgroup.co.uk within the Investor Relations section.  In accordance with Listing Rule 9.6.1, the Annual Report has also been uploaded to National Storage Mechanism, and will also shortly be available for viewing.
 
Disclosure & Transparency Rule ("DTR") 6.3.5 requires the Company to disclose to the media certain information from its Annual Report, if that information is of a type that would be required to be disseminated in a half-yearly report.  Accordingly, this announcement should be read in conjunction with and is not a substitute for reading the full Annual Report. Together these constitute the information required by DTR 6.3.5, which is required to be communicated in unedited full text through a Regulatory Information Service.
 
The information included in this announcement is extracted from the Annual Report which was approved by the Directors on 28 November 2016.  Defined terms used in the announcement refer to terms as defined in the Annual Report unless the context otherwise requires.
 
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.
 
ANNUAL GENERAL MEETING
 
The Company also today gives notice that its Annual General Meeting will be held at the offices of Stephenson Harwood LLP, 1 Finsbury Circus, London EC2M 7SH at 11.30 am on 3 March 2016.
 
The Annual Report and Notice of Annual General Meeting will be posted to shareholders in due course

Receipt of �1m deferred consideration
RNS
RNS Number : 2467S
Premier Veterinary Group PLC
19 December 2016
 
 
PREMIER VETERINARY GROUP plc
("PVG" or "the Company")
 
 
Receipt of £1m deferred consideration
 
 
 
London, UK, 19 December 2016 - Premier Veterinary Group plc (LSE: PVG) provides the following update:
 
As reported in the preliminary results announcement on 29 November 2016, the Group's statement of financial position as at 30 September 2016 contained an amount of £1m receivable which related to deferred consideration for the sale of its veterinary practices in December 2015.  This amount had been held in escrow to cover potential liabilities under warranty and indemnity provisions in the sale and purchase agreement.  The full value of the £1m escrow balance has now been received, in line with directors' expectations. 
The Annual Report and Accounts for the year ended 30 September 2016 (the "Annual Report") will be posted to shareholders by the end of December, together with the Notice of Annual General Meeting which is to be held at 11.30 am on 3 March 2017 at the offices of Stephenson Harwood LLP, 1 Finsbury Circus, London EC2M 7SH.  A full copy of the Annual Report (incorporating the Notice of Annual General Meeting) is also available on the Company's  website at www.premiervetgroup.co.uk within the Investor Relations section.

Loan note and growth update

Premier Veterinary hits new high as pet plan numbers leap

Tue, 31 January 2017






(ShareCast News) - Premier Veterinary Group has enjoyed a 48% increase in the number of pets on its preventative healthcare programme helped by a 11% leap in the last quarter.
Premier's recurring revenue streams are driven by the number of pets that are signed up to the Premier Pet Care Plan.

As at the end of December, there were 132 pets on the plan in the UK, 21 in Europe and a first in the US, meaning the total of 154 compares to the 104 a year before.

Shares in Premier Vet hit 215p just after the announcement on Tuesday afternoon, their highest level since reversing into Ark Therapeutics in 2014.

Holding(s) company increases

FURTHER AGREEMENT IN US FOR PREMIER PET CARE PLAN
RNS
RNS Number : 0180X
Premier Veterinary Group PLC
16 February 2017
 
 
PREMIER VETERINARY GROUP PLC
("PVG" or "the Company")
 
 
FURTHER CO-OPERATION AGREEMENT SIGNED IN THE US FOR
PREMIER PET CARE PLAN
London, UK, 16 February 2017 - Premier Veterinary Group plc (LSE: PVG) announces that its wholly-owned subsidiary, Premier Vet Alliance (US) Limited ("PVA"), has signed a co-operation agreement with Midwest Veterinary Supply, Inc ("Midwest"), a major veterinary distributor based out of Minnesota, US.
The initial 5-year co-operation agreement is to introduce the Company's preventative healthcare programme for pets, branded "Premier Pet Care Plan" ("PPCP"), to Midwest's client hospitals, numbering over 12,000 across 35 States, located primarily in the Mid West and South East of the US.
 
Jeff Burkhamer, National Sales Manager, Midwest Veterinary Supply, Inc commented:
"Midwest is very familiar with preventative healthcare plans, but PVA is the first to come to us with a model that delivers a product led programme with a comprehensive support package and delivering an end-to-end solution.  We are a customer focused company and believe that the Premier Pet Care Plan will deliver real added value to our hospitals."
Dominic Tonner, Chief Executive Officer of PVG, added:
"We are delighted to have secured such a prestigious contract with a highly respected industry player, and we look forward to a rapid and successful roll-out of our Premier Pet Care Plan across the Midwest client base."
Update on US market
The Midwest co-operation agreement is the third co-operation agreement entered into since PVG announced its entry to the US market in May 2016, providing PVG with the opportunity to access a significant segment of the available US market. The total number of dogs and cats across the US is estimated at 70 million and 74 million respectively (U.S. Pet Ownership & Demographics Sourcebook 2012).
In early June 2016, the Company announced that it had signed a major agreement with Veterinary Products, Inc. ("VPI"), a significant veterinary distributor co-op, headquartered in Atlanta, Georgia, US to promote and roll-out the Company's PPCP to VPI's member hospitals, which at that time numbered over 600 across 15 States, located primarily in the South East of the US.
At the end of June 2016, the Company issued a further announcement confirming that it had signed another major agreement in the US for PPCP.  That agreement was entered into with Merritt Veterinary Supplies Inc. ("MVS"), a leading veterinary supplies distributor founded in 1938, which at that time had 9,000 member hospitals in the South East of the US. MVS is headquartered in Columbia, South Carolina. 
The continued rapid rate of expansion into the US has given PVG the confidence to accelerate its investment programme in terms of people and infrastructure, including further investment in additional functionality and data capture within PVG's bespoke software system.

Update ahead of agm

No volume, up 11%

Vets flying.

Premier Veterinary warns it will take longer to become competitive in US
StockMarketWire.com
Premier Veterinary warned that it expects it to take an extra six months to become competitive in the US.

This news emerged after it identified changes to its business model that would be implemented after finding differences between the US and UK markets.

Earlier this year, the company provided an update on its activities in the US conducted through its wholly owned subsidiary, Premier Vet Alliance (US).

It expressed its confidence in the prospects for the US business and an intent to significantly increase its investment in sales, launch and business infrastructure to take the opportunity to build market share in future periods. This investment was to be funded by the proposed disposal of its buying group.

Premier Veterinary said additional investment in the US was being made and the number of hospital sign ups and pets on plan continued to increase.

Given the strong pipeline of sales, the board remained confident the opportunity to access a significant segment of the available US market still existed.

At 12:04pm: (LON:PVG) Premier Veterinary Group PLC share price was -62.88p at 177.5p

Going well.